Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vsee Health (VSEE) EBITDA (2023 - 2025)

Historic EBITDA for Vsee Health (VSEE) over the last 3 years, with Q3 2025 value amounting to -$2.1 million.

  • Vsee Health's EBITDA rose 9647.05% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.2 million, marking a year-over-year increase of 8451.85%. This contributed to the annual value of -$62.2 million for FY2024, which is 321720.8% down from last year.
  • According to the latest figures from Q3 2025, Vsee Health's EBITDA is -$2.1 million, which was up 9647.05% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Vsee Health's EBITDA ranged from a high of $104060.0 in Q1 2024 and a low of -$58.3 million during Q3 2024
  • In the last 3 years, Vsee Health's EBITDA had a median value of -$932523.0 in 2024 and averaged -$6.4 million.
  • Examining YoY changes over the last 5 years, Vsee Health's EBITDA showed a top increase of 11453.65% in 2024 and a maximum decrease of 1641107.7% in 2024.
  • Vsee Health's EBITDA (Quarter) stood at -$114831.0 in 2023, then tumbled by 2536.38% to -$3.0 million in 2024, then skyrocketed by 32.04% to -$2.1 million in 2025.
  • Its EBITDA was -$2.1 million in Q3 2025, compared to -$2.3 million in Q2 2025 and -$1.8 million in Q1 2025.